Advanced Therapies Europe 2026

Advanced Therapies Europe 2026, an event organized by Phacilitate, will take place from September 7 to 9, 2026, in Barcelona, Spain.

The opportunity to participate in a key event that brings together European leaders in advanced therapies, as well as experts, developers, and regulators, to discuss the latest developments in the research, development, and commercialization of cellular, gene, and regenerative therapies should not be missed.

Advanced Therapies Europe provides a unique platform for collaboration, knowledge exchange, and the creation of synergies that drive the future of personalized and innovative medicine.

Whether you are launching a new therapy, seeking strategic partnerships, or aiming to anticipate regulatory and market changes, Advanced Therapies Europe is designed to provide you with practical insights and meaningful connections.

• Expand your network – Meet CEOs from biotechnology, pharmaceutical strategists, CDMO leaders, and investors who are shaping the next wave of therapeutic innovation.
• Gain strategic perspective – Access expert-led industry sessions on regulation, funding trends, scaling solutions, and commercial strategy.
• Discover what lies ahead – Explore the latest advances in cell and gene therapy platforms, biotechnological technologies, and regenerative medicine.

The topics of interest at Advanced Therapies Europe include biotechnology investment, focusing on opportunities for startups and investors, as well as women's leadership and inclusivity in the sector. Key discussions will cover the scaling and production of gene and cell therapies, particularly in AAV manufacturing, and the European regulations and regulatory challenges. Additionally, important topics such as patient access to treatments and the industrialization of cell therapies will be addressed, aiming to overcome barriers to their clinical implementation.

07/09/2026

09:15h - 09:55h | Workshop Room

What it takes to fund advanced therapies in 2026

• Artemy Shumskiy, Principal - LongeVC
• Gadareth Higgs, Partner - Advantary Capital Partners
• Laura Rodriguez, Partner - Invivo Partners
• Malgorzata Rogalska, Analyst - Ysios Capital
• Rahul Khetan, Venture Associate - UCB Ventures

10:50h - 11:30h | Workshop Room

Differentiation or bust: How to stand out in a saturated market

• Francisca Peixoto, Co-Founder and Managing Partner - LifeLink Ventures
• Jose Mesa, Partner - Columbus Venture Partners
• Marc Ramis Castelltort, Founder & Managing Partner - Montana

08/09/2026

09:05h - 09:45h | Theatre 1&2

Europe’s ATMP rulebook reset: The 12-month pathway from fragmented rules to trusted EU execution

• Esteve Trias, Executive Medical Director and Technical Director of Advanced Therapies Unit - Hospital Clínic de Barcelona
• Sean Russell, Managing Partner - PrimeRA Pharma Partners

10:20h - 11:00h | Theatre 1&2

Winning the next wave of ATMP R&D: What Europe must resolve to compete on speed, scale and return

• Bo Wiinberg, CBO - Novo Nordisk Foundation Cellerator
• Miguel Forte, CEO - Kiji Therapeutics
• Montse Daban, Director of Strategic Foresight and International Relations - BIOCAT
• Paolo Morgese, Vice President Public Affairs, Europe - Alliance for Regenerative Medicine

12:00h - 12:30h | Theatre 1

CGT clinical trials at pace: What’s accelerating, what’s stuck and how Europe turns trials into treatments

• Cristina Salado, Assistant Professor - Universitat Pompeu Fabra
• Esther Kitto, VP Clinical Operations - Resolution Therapeutics
• Joana Claverol, Head of Clinical Research Unit - Sant Joan de Deu
• Manel Juan Otero, Head of Immunology - Hospital Clínic de Barcelona

16:15h - 17:15h

When venture philanthropy meets venture creation | Workshop Room

• Gonzalo Fernandez-Miranda, Co-founder & CEO - CureAge Therapeutics

09/09/2026

10:30h - 11:15h |  Theatre 1&2

Designing CGTs in the age of agentic AI: How to accelerate discovery and development without losing regulatory control

• Aneta Tyszkiewicz, Director Data Digital - EFPIA - European Federation of Pharmaceutical Industries and Associations
• Clara Cuervo, Head of AI and Digital Transformation Cell Therapy Clinical Operations Global - AstraZeneca
• Marc Guell, Cofounder & Scientific Head - Integra Therapeutics
• Vasiliki Kalodimou, Assistant Professor - European University Cyprus

Over the course of three days, Advanced Therapies Europe 2025 transformed the Hotel Arts in Barcelona into a meeting point for 500 advanced therapies professionals, mostly from Europe (55%) and with nearly one-third local and national representation (27%). These figures confirmed the growing role of the Catalan capital as a European hub in this field.